Browse Category

SWX:ROG.SW News 20 December 2025

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

As of December 20, 2025, healthcare stocks are heading into year-end with a rare mix of policy clarity and policy risk—often at the same time. In the past 48 hours, the sector has been hit by major U.S. drug-pricing announcements, renewed focus on insurance premiums, and a fresh run of deal and IPO headlines that are reshaping investor expectations for…

Stock Market Today

  • Planet Labs PBC Shares Slide 7.2% Amid Mixed Analyst Ratings
    February 3, 2026, 12:56 AM EST. Planet Labs PBC (NYSE:PL) saw its shares drop 7.2% to $23.18 on Monday, with trading volume falling 52% below average. Despite beating quarterly earnings estimates with $0.00 EPS versus a forecasted loss of $0.02, the stock faces mixed analyst sentiment. The consensus rating stands at "Hold" with a target price of $20.64, reflecting cautious optimism. The company reported a 32.6% revenue increase year-over-year to $81.25 million but continues to show a negative net margin near 46%. Insider selling was notable, with director Vijaya Gadde offloading 20,000 shares at $26.77 each. Planet Labs holds a market cap of $7.18 billion and a high beta of 1.94, indicating elevated volatility.
Go toTop